722 related articles for article (PubMed ID: 28179575)
1. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
2. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
3. [Precision medicine in oncology].
Mack E
Inn Med (Heidelb); 2024 Mar; 65(3):194-201. PubMed ID: 37921995
[TBL] [Abstract][Full Text] [Related]
4. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
[TBL] [Abstract][Full Text] [Related]
5. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.
Casolino R; Beer PA; Chakravarty D; Davis MB; Malapelle U; Mazzarella L; Normanno N; Pauli C; Subbiah V; Turnbull C; Westphalen CB; Biankin AV
CA Cancer J Clin; 2024; 74(3):264-285. PubMed ID: 38174605
[TBL] [Abstract][Full Text] [Related]
6. [Precision oncology and molecular tumor boards].
Mack E; Horak P; Fröhling S; Neubauer A
Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
[TBL] [Abstract][Full Text] [Related]
7. Progress in precision therapy in pediatric oncology.
O'Donohue T; Farouk Sait S; Glade Bender J
Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
[TBL] [Abstract][Full Text] [Related]
8. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling for precision cancer therapies.
Malone ER; Oliva M; Sabatini PJB; Stockley TL; Siu LL
Genome Med; 2020 Jan; 12(1):8. PubMed ID: 31937368
[TBL] [Abstract][Full Text] [Related]
10. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
[TBL] [Abstract][Full Text] [Related]
11. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
12. Genomic medicine: new frontiers and new challenges.
Pasic MD; Samaan S; Yousef GM
Clin Chem; 2013 Jan; 59(1):158-67. PubMed ID: 23284016
[TBL] [Abstract][Full Text] [Related]
13. Precision Medicine: Steps along the Road to Combat Human Cancer.
Nassar SF; Raddassi K; Ubhi B; Doktorski J; Abulaban A
Cells; 2020 Sep; 9(9):. PubMed ID: 32916938
[TBL] [Abstract][Full Text] [Related]
14. Building a personalized medicine infrastructure at a major cancer center.
Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
[TBL] [Abstract][Full Text] [Related]
15. Genomics-Guided Immunotherapy for Precision Medicine in Cancer.
Mukherjee S
Cancer Biother Radiopharm; 2019 Oct; 34(8):487-497. PubMed ID: 31314580
[TBL] [Abstract][Full Text] [Related]
16. Personalized
Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
[TBL] [Abstract][Full Text] [Related]
17. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards.
Fujiwara Y; Kato S; Kurzrock R
Surg Oncol Clin N Am; 2024 Apr; 33(2):197-216. PubMed ID: 38401905
[TBL] [Abstract][Full Text] [Related]
18. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.
Ginsburg GS; Kuderer NM
J Clin Oncol; 2012 Dec; 30(34):4233-42. PubMed ID: 23071236
[TBL] [Abstract][Full Text] [Related]
20. Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.
Armstrong AJ; Li X; Tucker M; Li S; Mu XJ; Eng KW; Sboner A; Rubin M; Gerstein M
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):786-793. PubMed ID: 33568750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
